• Study on Niraparib and Dostarlimab for Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study on Trastuzumab Deruxtecan for Patients with Metastatic HER2-Positive Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany Greece The Netherlands Romania
  • Study of [18F]FAPI-74 PET/CT Imaging in Patients with Connective Tissue Disease at Risk of Lung Fibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of RLS-0071 Treatment for Hospitalized Patients with Steroid-Resistant Acute Graft-versus-Host Disease (aGvHD)

    Not recruiting

    2 1 1
    Investigated Diseases:
    Germany Spain
  • Study of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Spain
  • Study of Durvalumab with Thoracic Radiotherapy and Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer After Initial Treatment

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study on the Effects of Apixaban, Acetylsalicylic Acid, and Rivaroxaban on Heart Valve Thickening in Patients with Aortic Valve Replacement

    Not recruiting

    3 1 1 1
    Denmark
  • Study on the Use of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treating Ulcerative Colitis in Patients

    Not recruiting

    1 1 1
    Denmark

powered by